Reuters - Western generic drugmakers need to adapt to cope with rapid changes in the pharmaceuticals market that are blurring the distinctions between innovator companies and makers of cheaper copycat products.
You are here:
Health 
Diseases & Conditions Actavis prepares for end of generic drugs model
(Reuters)
Diseases & Conditions Actavis prepares for end of generic drugs model
(Reuters)
